These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7906007)

  • 1. New medications for the schizophrenias.
    Keks NA; Burrows GD
    Med J Aust; 1994 Jan; 160(2):53-4. PubMed ID: 7906007
    [No Abstract]   [Full Text] [Related]  

  • 2. [Deficit schizophrenias].
    Puech AJ
    Encephale; 1996 Jun; 22 Spec No 2():1. PubMed ID: 8767033
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of schizophrenia patients: comparing new-generation antipsychotics to each other.
    Fleischhacker WW; Widschwendter CG
    Curr Opin Psychiatry; 2006 Mar; 19(2):128-34. PubMed ID: 16612191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs.
    Miyamoto S; Duncan GE; Marx CE; Lieberman JA
    Mol Psychiatry; 2005 Jan; 10(1):79-104. PubMed ID: 15289815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic medication: the literature and implications for mental health nursing.
    Usher K; Happell B
    Aust N Z J Ment Health Nurs; 1996 Dec; 5(4):191-8. PubMed ID: 9079316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent developments in chemotherapeutic treatment].
    Bange F
    Soins Psychiatr; 1993; (154-155):41-9. PubMed ID: 7907190
    [No Abstract]   [Full Text] [Related]  

  • 7. Cognitive improvement in response to antipsychotic drugs: neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
    Heinrichs RW
    Arch Gen Psychiatry; 2007 Jun; 64(6):631-2. PubMed ID: 17548745
    [No Abstract]   [Full Text] [Related]  

  • 8. New medication for the schizophrenias.
    Kazlauskas K
    Med J Aust; 1994 May; 160(9):590. PubMed ID: 7909351
    [No Abstract]   [Full Text] [Related]  

  • 9. Benefits of atypical antipsychotic medications in the treatment of psychosis.
    White DL
    Kans Nurse; 2003; 78(10):1-2. PubMed ID: 14746070
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clozapine and schizophrenias: 1991-1996].
    Lôo H; Olié JP
    Encephale; 1996 Dec; 22 Spec No 6():1-2. PubMed ID: 9102312
    [No Abstract]   [Full Text] [Related]  

  • 11. [Application of pharmacotherapy with classic neuroleptics: phenothiazine derivatives in schizophrenia].
    Kleszczewska E; Hejza J
    Pol Merkur Lekarski; 2003 Feb; 14(80):136-8. PubMed ID: 12728674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of neuroleptic medications on continuous performance test measures in schizophrenia.
    Epstein JI; Keefe RS; Roitman SL; Harvey PD; Mohs RC
    Biol Psychiatry; 1996 May; 39(10):902-5. PubMed ID: 8860194
    [No Abstract]   [Full Text] [Related]  

  • 13. Research methodology and the pharmacotherapy of the chronic schizophrenias.
    Ban TA; Guy W; Wilson WH
    Psychopharmacol Bull; 1986; 22(1):36-41. PubMed ID: 2873618
    [No Abstract]   [Full Text] [Related]  

  • 14. What's atypical about atypical antipsychotic drugs?
    Meltzer HY
    Curr Opin Pharmacol; 2004 Feb; 4(1):53-7. PubMed ID: 15018839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New drugs for schizophrenia: an update for family physicians.
    Amadio PB; Cross LB; Amadio P
    Am Fam Physician; 1997 Sep; 56(4):1149-56, 1159-60. PubMed ID: 9310066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [From neuroleptics toward antipsychotics: quality of life and schizophrenia].
    Lançon C
    Encephale; 2003 Sep; 29(Pt 2):S43-6. PubMed ID: 14710537
    [No Abstract]   [Full Text] [Related]  

  • 17. First-episode schizophrenia. Early intervention and medication discontinuation in the context of course and treatment.
    Wyatt RJ; Damiani LM; Henter ID
    Br J Psychiatry Suppl; 1998; 172(33):77-83. PubMed ID: 9764131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of schizophrenia drugs: a focus on dopaminergic systems.
    Nikam SS; Awasthi AK
    Curr Opin Investig Drugs; 2008 Jan; 9(1):37-46. PubMed ID: 18183530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do atypical antipsychotic agents have a role in the treatment of depression?
    Bailey KP
    J Psychosoc Nurs Ment Health Serv; 2003 Oct; 41(10):12-6. PubMed ID: 14571629
    [No Abstract]   [Full Text] [Related]  

  • 20. [Success of new treatments for schizophrenics, as shown by the example of modern antipsychotic drugs].
    Lambert M; Naber D; Perro C; Moritz S; Krausz M
    Psychiatr Prax; 1999 Apr; 26 Suppl 1():S30-5. PubMed ID: 10407922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.